piroxantrone has been researched along with Leukocytopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberts, DS; Conrad, ME; Goldberg, DA; Hantel, A; Liu, PY; Malviya, VK; O'Toole, RV; Roach, RW | 1 |
| Clarke, BV; Donehower, RC; Ettinger, DS; Grochow, LB; Hantel, A; McGuire, WP; Noe, DA; Rowinsky, EK; Vance, E | 1 |
1 trial(s) available for piroxantrone and Leukocytopenia
| Article | Year |
|---|---|
A phase II trial of piroxantrone in endometrial cancer: Southwest Oncology Group study 8918.
Topics: Adult; Aged; Agranulocytosis; Anthraquinones; Antineoplastic Agents; Endometrial Neoplasms; Female; Humans; Leukopenia; Middle Aged; Nausea; Pyrazoles | 1996 |
1 other study(ies) available for piroxantrone and Leukocytopenia
| Article | Year |
|---|---|
Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazole.
Topics: Adult; Aged; Anthraquinones; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Heart; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Pyrazoles | 1990 |